Tilmann Lantzsch

1.4k total citations
26 papers, 819 citations indexed

About

Tilmann Lantzsch is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Tilmann Lantzsch has authored 26 papers receiving a total of 819 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 10 papers in Cancer Research and 5 papers in Molecular Biology. Recurrent topics in Tilmann Lantzsch's work include Breast Cancer Treatment Studies (6 papers), Cell Adhesion Molecules Research (3 papers) and Bone health and treatments (2 papers). Tilmann Lantzsch is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Cell Adhesion Molecules Research (3 papers) and Bone health and treatments (2 papers). Tilmann Lantzsch collaborates with scholars based in Germany, Austria and Switzerland. Tilmann Lantzsch's co-authors include Heinz Koelbl, Lukas Hefler, Christoph Grimm, Alexander Reinthaller, G. Sliutz, Antje Lebrecht, Eva Ulbrich, J Buchmann, Dieter Lampe and Elisabeth Ludwig and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Tilmann Lantzsch

23 papers receiving 803 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tilmann Lantzsch Germany 14 294 237 209 172 157 26 819
David N. Brown United States 19 265 0.9× 426 1.8× 342 1.6× 207 1.2× 197 1.3× 46 1.0k
Antonio De Leo Italy 17 228 0.8× 191 0.8× 155 0.7× 164 1.0× 71 0.5× 101 869
Sung‐Im Do South Korea 16 340 1.2× 399 1.7× 258 1.2× 145 0.8× 55 0.4× 84 913
Yuko Sasajima Japan 19 375 1.3× 358 1.5× 248 1.2× 235 1.4× 240 1.5× 94 1.2k
Malti Kshirsagar United States 9 218 0.7× 201 0.8× 176 0.8× 94 0.5× 58 0.4× 9 603
Martin E. Bur United States 11 214 0.7× 172 0.7× 202 1.0× 84 0.5× 67 0.4× 17 825
Koji Kumagai Japan 23 174 0.6× 287 1.2× 122 0.6× 119 0.7× 69 0.4× 83 1.5k
Tyler P. Robin United States 17 608 2.1× 330 1.4× 198 0.9× 272 1.6× 195 1.2× 55 1.3k
Linda N. Dao United States 10 251 0.9× 208 0.9× 67 0.3× 51 0.3× 81 0.5× 29 723
Darren Wheeler United States 15 262 0.9× 167 0.7× 129 0.6× 285 1.7× 100 0.6× 30 1.1k

Countries citing papers authored by Tilmann Lantzsch

Since Specialization
Citations

This map shows the geographic impact of Tilmann Lantzsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tilmann Lantzsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tilmann Lantzsch more than expected).

Fields of papers citing papers by Tilmann Lantzsch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tilmann Lantzsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tilmann Lantzsch. The network helps show where Tilmann Lantzsch may publish in the future.

Co-authorship network of co-authors of Tilmann Lantzsch

This figure shows the co-authorship network connecting the top 25 collaborators of Tilmann Lantzsch. A scholar is included among the top collaborators of Tilmann Lantzsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tilmann Lantzsch. Tilmann Lantzsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bauer, Marcus, Jochen Wilke, Volker Hanf, et al.. (2024). Prognostic and predictive impact of NOTCH1 in early breast cancer. Breast Cancer Research and Treatment. 209(1). 27–38.
2.
Bethmann, Daniel, Tilmann Lantzsch, Christoph Uleer, et al.. (2022). Prognostic Value of Tumour-Infiltrating Lymphocytes in an Unselected Cohort of Breast Cancer Patients. Diagnostics. 12(10). 2527–2527. 3 indexed citations
3.
Staege, Martin S., Volker Hanf, Tilmann Lantzsch, et al.. (2021). Identifying High-Risk Triple-Negative Breast Cancer Patients by Molecular Subtyping. Breast Care. 16(6). 637–647. 13 indexed citations
4.
Bauer, Marcus, Eva Johanna Kantelhardt, Thorsten Stiewe, et al.. (2019). Specific allelic variants of SNPs in the MDM2 and MDMX genes are associated with earlier tumor onset and progression in Caucasian breast cancer patients. Oncotarget. 10(20). 1975–1992. 7 indexed citations
5.
Bernhardt, Stephan, Michaela Bayerlová, Martina Vetter, et al.. (2017). Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors. Breast Cancer Research. 19(1). 112–112. 80 indexed citations
6.
Leplow, Bernd, et al.. (2016). Memory and Spatial Cognition in Breast Cancer Patients Undergoing Adjuvant Endocrine Therapy. Breast Care. 11(4). 240–246. 10 indexed citations
7.
Eggemann, Holm, Atanas Ignatov, Dirk Elling, et al.. (2013). Efficacy and Patient Satisfaction of Breast Conserving Therapy for Central Breast Cancer by the B Technique. Annals of Surgical Oncology. 20(11). 3438–3445. 8 indexed citations
8.
Lantzsch, Tilmann, Dieter Lampe, & Eva Johanna Kantelhardt. (2013). Correction of Poland's Syndrome: Case Report and Review of the Current Literature. Breast Care. 8(2). 139–142. 10 indexed citations
9.
Witzel, Isabell, Sibylle Loibl, G von Minckwitz, et al.. (2010). Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial. Breast Cancer Research and Treatment. 123(2). 437–445. 37 indexed citations
10.
11.
Kluttig, Alexander, Pietro Trocchi, A. Heinig, et al.. (2007). Reliability and validity of needle biopsy evaluation of breast-abnormalities using the B-categorization – design and objectives of the Diagnosis Optimisation Study (DIOS). BMC Cancer. 7(1). 100–100. 10 indexed citations
12.
Hefler, Lukas, Christoph Grimm, Tilmann Lantzsch, et al.. (2006). Polymorphisms of the endothelial nitric oxide synthase gene in breast cancer. Breast Cancer Research and Treatment. 98(2). 151–155. 31 indexed citations
13.
Gradhand, Elise, Wolfgang Schmitt, Tilmann Lantzsch, et al.. (2006). Ezrin Promotes Ovarian Carcinoma Cell Invasion and Its Retained Expression Predicts Poor Prognosis in Ovarian Carcinoma. International Journal of Gynecological Pathology. 25(2). 121–130. 58 indexed citations
14.
Hefler, Lukas, Christoph Grimm, Tilmann Lantzsch, et al.. (2005). Interleukin-1 and Interleukin-6 Gene Polymorphisms and the Risk of Breast Cancer in Caucasian Women. Clinical Cancer Research. 11(16). 5718–5721. 100 indexed citations
15.
Lebrecht, Antje, Christoph Grimm, E. Ludwig, et al.. (2004). Transforming growth factor beta 1 serum levels in patients with preinvasive and invasive lesions of the breast. The International Journal of Biological Markers. 19(3). 236–239. 15 indexed citations
16.
Lebrecht, Antje, Christoph Grimm, Tilmann Lantzsch, et al.. (2004). Monocyte Chemoattractant Protein-1 Serum Levels in Patients with Breast Cancer. Tumor Biology. 25(1-2). 14–17. 117 indexed citations
17.
Sliutz, G., Alexander Reinthaller, Tilmann Lantzsch, et al.. (2002). Lymphatic Mapping of Sentinel Nodes in Early Vulvar Cancer. Gynecologic Oncology. 84(3). 449–452. 100 indexed citations
18.
Lantzsch, Tilmann, et al.. (2001). Sentinel node procedure in Ib cervical cancer: a preliminary series. British Journal of Cancer. 85(6). 791–794. 76 indexed citations
19.
Lantzsch, Tilmann, et al.. (2001). Sertoli-Leydig cell tumor. Archives of Gynecology and Obstetrics. 264(4). 206–208. 44 indexed citations
20.
Lantzsch, Tilmann, et al.. (2001). Sacrospinous ligament fixation for vaginal vault prolapse. Archives of Gynecology and Obstetrics. 265(1). 21–25. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David N. Brown Breakdown of academic impact, for papers by Antonio De Leo Breakdown of academic impact, for papers by Sung‐Im Do Breakdown of academic impact, for papers by Yuko Sasajima Breakdown of academic impact, for papers by Malti Kshirsagar Breakdown of academic impact, for papers by Martin E. Bur Breakdown of academic impact, for papers by Koji Kumagai Breakdown of academic impact, for papers by Tyler P. Robin Breakdown of academic impact, for papers by Linda N. Dao Breakdown of academic impact, for papers by Darren Wheeler
Rankless by CCL
2026